-
TheraPEAK® P3 Primary Cell Nucleofector® Solution Set (22.5 mL + 5 mL)Catalog #: G4LP3-22500
For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
Sales unit: items -
TheraPEAK® P3 Primary Cell Nucleofector® Solution Set (126 mL + 28 mL)Catalog #: G4LP3-126000
For use in combination with TheraPEAK® Nucleocuvette® Cartridges, supporting the use of the 4D-Nucleofector® LV Unit in a GMP environment.
Sales unit: items -
DonorPlex™ Pooled Donor Human Hepatocytes, 50 Donor, Mixed GenderCatalog #: HUCS50PPooled 50-donor, mixed-gender human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.Sales unit: Ampule
-
DonorPlexTM Pooled Donor Human Hepatocytes, 10 Donor, FemaleCatalog #: HUCS10PFPooled 10-donor female only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.Sales unit: Ampule
-
DonorPlexTM Pooled Donor Human Hepatocytes, 20 Donor, FemaleCatalog #: HUCS20PFPooled 20-donor, female only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.Sales unit: Ampule
-
DonorPlexTM Pooled Donor Human Hepatocytes, 10 Donor, MaleCatalog #: HUCS10PM
Pooled 10-donor, male human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Sales unit: Ampule -
DonorPlexTM Pooled Donor Human Hepatocytes, 10 donor, mixed genderCatalog #: HUCS10P
Pooled 10-donor, mixed-gender human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Sales unit: Ampule -
DonorPlexTM Pooled Donor Human Hepatocytes, 20 Donor, MaleCatalog #: HUCS20PM
Pooled 20-donor male only human hepatocytes that are characterized for multiple CYP450, UGT, SULT, and transporter activities. Ideal for drug metabolite identification, characterization, and turnover kinetics.
Sales unit: Ampule
-
The Compendia are ready. Are you?Explore the new regulatory landscape for rFC and MAT as the assays gain global approval. rFC and MAT are no longer the 'alternatives'.
-
Poietics® Human Bone MarrowInformation for Lonza bone marrow primary cell products
-
Webinar - Hepatocytes in the drug development pipelineOverview of how primary hepatocytes are used in drug development
-
Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic ResearchLonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
-
Advancing Bone Disease Research – Dissociated Rat Calvariae Osteoblasts Display Optimal Mineralization and Are Easily Transfected Using NucleofectionThe data provided in this white paper show the quality and sensitivity of cryopreserved dissociated rat calvariae osteoblasts for in vitro studies. Furthermore, application of the 4D-Nucleofector™ System for efficient transfection of dissociated osteoblasts represents a significant advantage for investigating bone biology.
-
PYROSTAR™ ES-F Series BrochureThe PYROSTAR™ ES-F series of reagents are endotoxin-specific and unreactive to β-D-Glucan
-
Confidence for adopting the rFC method in your labFact-based reference materials for those companies who are considering adopting the rFC method in their labs.
-
Troubleshooting Guide - PYROGENT® Gel Clot LAL AssayMost problems encountered in the use of the PYROGENT® Gel Clot Limulus Amebocyte Lysate (LAL) Assay fall into two basic categories - no firm gels are observed in reaction tubes where firm gels are expected or firm gels form in reaction tubes, which are expected to yield negative results. This Tech Tip takes a deeper look into each of these categories and provides troubleshooting guidance.
-
Expanded HUVECs for High-throughput ScreeningHUVECs are a good primary endothelial cell type for many in vitro studies and also for several high-throughput screening applications. Consequently, Lonza offers, HUVEC-XL. These cells are expanded to passage-3 from pooled P1-HUVECs and packaged at 10 million cells per ampoule.
-
NPCs Hepatic Non-Parenchymal CellsThese additional liver cell types provide a complete building set supporting complex cell culture modeling. Applications include developing more physiologically relevant in vitro models for complex liver diseases and toxicity testing of new drugs and chemicals.